SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Lifecycle management

News in brief

Sanofi targets rural India with generics campaign

14-Dec-2009 - Sanofi Aventis plans to launch 15 new generic products in rural India, under its new Prayas marketing initiative being rolled out through its Hoechst brand.

News in brief

Teva and H Lundbeck raided in latest EC antitrust probe

10-Dec-2009 - Officials carried out another set of surprise inspections at pharma companies yesterday, in the latest stage of the European Commission's clampdown on anti-competitive practices.

News in brief

Teva extends Codexis biocatalyst deal

09-Dec-2009 - Teva will continue to use Codexis’ biocatalysis technology for key processing steps in the production of four generic drugs under a revised agreement announced last week.

Ratiopharm race heats up: Sanofi, Teva and Sinopharm in the lead

09-Dec-2009 - Sanofi-Aventis, Teva Pharmaceutical Industries and Sinopharm lead the pack in the race to acquire German generics firm Ratiopharm.

Watson completes Arrow deal, adding generic Lipitor to US portfolio

07-Dec-2009 - Watson Pharmaceuticals gained US rights to market a generic version of Lipitor (atorvastatin) in 2011 with the acquisition of non-branded drugmaker Arrow Group late last week.

Genzyme ships Cerezyme again; Pfizer licenses Protalix’ rival

03-Dec-2009 - Pfizer and Protalix have increased the pressure on Genzyme by signing a new accord to commercialise Uplyso (taliglucerase alfa), a potential rival to its Gaucher’s disease treatment Cerezyme, just days...

Avon gains on US OK for Ranbaxy’s valacyclovir

02-Dec-2009 - Indian API maker Avon Organics’ share price rocketed 10 per cent on the Bombay exchange yesterday after the US launch of a generic herpes treatment by Ranbaxy Laboratories.

Generics hot up: Cipla in talks with Big Pharma; Takeda mulls M&As

01-Dec-2009 - India’s Cipla is in talks with a number of global pharma players, including Pfizer, about potential generics supply deals.

News in brief

Pharma faces tax hike, says PwC

01-Dec-2009 - The Pharma sector’s shift away from blockbusters could result in higher taxes according to PricewaterhouseCoopers (PwC).

News in brief

Servier’s Irish R&D and manufacturing plant opens

24-Nov-2009 - French drugmaker Servier has opened a new €47m manufacturing and R&D facility in Ireland.

Pfizer may join Japanese generics market in 2011

23-Nov-2009 - Just weeks after completing its billion dollar Wyeth takeover, US drug giant Pfizer has floated the idea of entering Japan’s $5.8bn (€3.9bn)-a-year generic drugs market in 2011 in a bid...

BASF talks novel excipients

18-Nov-2009 - The FDA encourages innovation in excipients to develop new drugs or improve approved therapeutics and IPEC is helping to drive acceptance of these novel products, according to BASF.

Influenza: statins may help, but did aspirin misuse hinder in 1918?

02-Nov-2009 - Early-stage CDC research suggests that the anti-inflammatory properties of cholesterol-busting statin drugs can help mitigate the impact of flu infection.

News in brief

Pfizer, GSK and Bayer accept Ecuador’s plan to break patents

29-Oct-2009 - Late last week Ecuador’s government announced plans to sidestep patents on more than 2,000 drugs, enabling them to produced local or imported as “generics”

Valois discusses what patients want from a device

20-Oct-2009 - Patients want nasal delivery devices that are portable, hygienic and can be used discretely, according to a director at Valois who delivered a talk on the company’s side-actuated product at...

EC GMP directive “still alive”; Cargill

19-Oct-2009 - The EC’s plan to make excipients comply with GMP is “still alive”, according to Cargill which spoke to in-PharmaTechnologist at CPhI about its Zerose erythritol product that it claims can...

Critical gains funding for hGH nasal delivery

19-Oct-2009 - Critical Pharmaceuticals has received a £1.5m ($2.4m) award to develop its hGH nasal spray, the market for which could be sizeable as company’s attempt to differentiate in response to generic...

ACRO wants trials for most biosimilars

15-Oct-2009 - ACRO says while a 12-year exclusivity period for innovative drugs is important for R&D, US legislation should include rules on trials for biosimilars

Stralfors says pack service plan can help drugmakers hit deadlines

15-Oct-2009 - Packaging group Stralfors says its recent collaboration with Novo Nordisk proves that its service plan is ideal for projects with strict time-to-market requirements.

CPhI 2009 show preview

08-Oct-2009 - We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.

Labopharm upbeat about depression drug after FDA OKs API maker

08-Oct-2009 - Canadian drugmaker Labopharm says its Italian API maker Gruppo Angelini has resolved all the US FDA concerns about processes used to make a once-a day version of the depression drug...

Genentech licenses SurModics tech for SR Lucentis

07-Oct-2009 - Its new microparticle technology licensing deal with Genentech could be worth as much as $200m (€136m) says US delivery specialist SurModics.

News in brief

Sanofi, Teva and Ratiopharm raided in EC competition probe

07-Oct-2009 - French drug major Sanofi Aventis, Israel's Teva Pharmaceutical Industries and Germany’s Ratiopharm were raided by European Commission (EC) competition officials yesterday as part of an ongoing investigation.

French govt unlikey to relinquish grip on health spending, says BMI

06-Oct-2009 - Despite the government’s “aggressive” promotion of generic drugs, pharmaceutical spending in France will continue to grow, according to new analysis by Business Monitor International (BMI).

Hospira buys facility & filgrastim rights to boost biogenerics

06-Oct-2009 - Hospira has acquired the worldwide rights to filgrastim and a Croatian biologics plant from Pliva, increasing its presence in the biogenerics field, and told in-PharmaTechnologist that further expansions are possible.

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products